SARS-CoV-2 variants found in the UK, Brazil and South Africa arose around the same time and share common features, suggesting to some scientists that the virus is undergoing "convergent evolution" and has a limited number of mutations left. Vaccine makers are adapting their formulas to counter the variants, and a limited number of mutations would simplify the task.